Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio (2016 - 2025)

Amphastar Pharmaceuticals has reported Debt Ratio over the past 13 years, most recently at 0.37 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.37 for Q4 2025, down 1.81% from a year ago — trailing twelve months through Dec 2025 was 0.37 (down 1.81% YoY), and the annual figure for FY2025 was 0.37, down 1.81%.
  • Debt Ratio for Q4 2025 was 0.37 at Amphastar Pharmaceuticals, up from 0.37 in the prior quarter.
  • Over the last five years, Debt Ratio for AMPH hit a ceiling of 0.41 in Q3 2023 and a floor of 0.06 in Q2 2021.
  • Median Debt Ratio over the past 5 years was 0.36 (2025), compared with a mean of 0.25.
  • Biggest five-year swings in Debt Ratio: fell 17.52% in 2021 and later skyrocketed 296.95% in 2023.
  • Amphastar Pharmaceuticals' Debt Ratio stood at 0.11 in 2021, then fell by 10.78% to 0.1 in 2022, then skyrocketed by 281.32% to 0.39 in 2023, then decreased by 2.17% to 0.38 in 2024, then decreased by 1.81% to 0.37 in 2025.
  • The last three reported values for Debt Ratio were 0.37 (Q4 2025), 0.37 (Q3 2025), and 0.38 (Q2 2025) per Business Quant data.